Showing results (171-180 of 415) with videos related to
Sort By:
Pageof 42
Cancer Research|March 1, 2005
Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imagingArvind P Pathak, Dmitri Artemov, B Douglas Ward, et al.American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics|April 29, 2006
Nonsurgical treatment of a patient with a Class III malocclusionAlexandros T Moullas, J Martin Palomo, Jedidiah R Gass, et al.Magnetic Resonance in Medicine|February 16, 2012
A method to determine the necessity for global signal regression in resting-state fMRI studiesGang Chen, Guangyu Chen, Chunming Xie, et al.AJSP: Reviews & Reports|July 14, 2020
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the LiteratureAlisha D Ware, Laura Wake, Patrick Brown, et al.Leukemia & Lymphoma|October 27, 2021
Risk factors for severe infections in secondary immunodeficiency: a retrospective US administrative claims study in patients with hematological malignanciesStephen Jolles, B Douglas Smith, Donald C Vinh, et al.Leukemia Research|November 21, 2020
Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypesBreann Yanagisawa, Brandy Perkins, Theodoros Karantanos, et al.Chemosphere|December 10, 2020
Thermal flux, fugitive gas emission and geotechnical instability in a complex tailings legacy siteGrant B Douglas, Ariane Ancel, Vincent Saille, et al.Head and Neck Pathology|February 22, 2021
Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad MassAmy S Duffield, Jonathan Webster, B Douglas Smith, et al.British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.Current Medical Research and Opinion|March 23, 2018
Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug developmentJaein Seo, B Douglas Smith, Elihu Estey, et al.Pageof 42